// App-Quantinova.ai

5541.0 : Prostate-specific antigen (PSA) kinetics in patients (pts) with advanced prostate cancer treated with apalutamide: Results from the TITAN and SPARTAN studies.

Researchers

Presenter

  • Kim N. Chi

Principal Investigators

  • Fred Saad

  • Simon Chowdhury

  • Julie N Graff

  • Neeraj Agarwal

  • Stephane Oudard

  • Gang Li

  • Angela Lopez-Gitlitz

  • Julie S. Larsen

  • Sharon Anne McCarthy

  • Suneel Mundle

  • Matthew Raymond Smith

  • Eric Jay Small

Medical Centers

  • Vancouver Prostate Centre, Vancouver, BC, Canada

  • Centre Hospitalier de lUniversite de Montreal/CRCHUM, University of Montreal, Montreal, QC, Canada

  • Guys, Kings and St. Thomas Hospitals, and Sarah Cannon Research Institute, London, United Kingdom

  • Portland VA Health Care System and Knight Cancer Institute, Oregon Health & Science University, Portland, OR

  • Hunstman Cancer Institute of Utah, Salt Lake City, UT

  • Georges Pompidou Hospital, University René Descartes, Paris, France

  • Janssen Research & Development, LLC, Raritan, NJ

  • Janssen Oncology, Los Angeles, CA

  • Janssen Research & Development, Los Angeles, CA

  • Janssen Oncology, Spring House, PA.

  • Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA

  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • Prostate specific antigen

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT02489318

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved